# Dynamic C-reactive protein trajectories predict prolonged healing time in diabetic wounds: a machine learning model based on a single-center cohort with standardized wound size

**Authors:** Sichao Jiang, Qixuan Song, Junhuan Wang, Xiaohong Sun, Zhen Zhang, Shouyu Wang, Junwei Zong

PMC · DOI: 10.3389/fmed.2026.1778003 · Frontiers in Medicine · 2026-02-12

## TL;DR

This study shows that changes in C-reactive protein levels can predict slow healing in diabetic wounds using a machine learning model.

## Contribution

A novel machine learning model using dynamic C-reactive protein trajectories to predict prolonged healing in diabetic wounds.

## Key findings

- The GradientBoosting model achieved high accuracy (0.9357) in predicting prolonged healing.
- CRP_2nd was identified as the most influential predictor of healing time.
- Higher albumin levels and favorable therapeutic responses were protective factors for healing.

## Abstract

To develop a machine learning (ML) model for predicting prolonged healing (>8 weeks) in diabetic wounds, focusing on dynamic C-reactive protein (CRP) trajectories.

This was a retrospective single-center cohort study. We included 465 patients with type 2 diabetes, standardized wound sizes (5–8 cm2), and debridement alone (2021–2024: training set, n = 325; 2025: temporal validation set, n = 140). Serial CRP was measured at admission (CRP), post-antibiotic preoperatively (CRP_2nd), and postoperatively at discharge (CRP_3rd). Therapeutic response variables (therapeutic_response_1/2/all) were calculated as percentage changes in serial CRP levels across treatment phases, reflecting anti-inflammatory/antimicrobial efficacy. LASSO regression selected features, 12 ML models were constructed, and performance was evaluated via AUC, sensitivity, and specificity. SHAP analysis interpreted predictions.

The GradientBoosting model exhibited superior performance (validation set: accuracy = 0.9357, sensitivity = 0.8689, specificity = 0.9873). LASSO regression identified 15 key variables [including CRP_2nd, CRP_3rd, albumin (ALB)]. SHAP analysis revealed CRP_2nd as the most influential predictor (mean absolute SHAP value = 0.460), with elevated CRP_2nd/CRP_3rd associated with prolonged healing and higher ALB/favorable therapeutic responses as protective factors.

Dynamic CRP trajectories, particularly CRP_2nd, are critical for predicting prolonged diabetic wound healing. The GradientBoosting model provides a clinically actionable tool for risk stratification.

## Linked entities

- **Diseases:** type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, MOK (MOK protein kinase) [NCBI Gene 5891] {aka RAGE, RAGE-1, RAGE1, STK30}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, RENBP (renin binding protein) [NCBI Gene 5973] {aka RBP, RNBP}, ELANE (elastase, neutrophil expressed) [NCBI Gene 1991] {aka ELA2, GE, HLE, HNE, NE, PMN-E}, ITIH2 (inter-alpha-trypsin inhibitor heavy chain 2) [NCBI Gene 3698] {aka H2P, ITI-HC2, SHAP}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, MMP8 (matrix metallopeptidase 8) [NCBI Gene 4317] {aka CLG1, HNC, MMP-8, PMNL-CL}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CALCA (calcitonin related polypeptide alpha) [NCBI Gene 796] {aka CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT}, TNNI3 (troponin I3, cardiac type) [NCBI Gene 7137] {aka CMD1FF, CMD2A, CMH7, RCM1, TNNC1, cTnI}, ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}
- **Diseases:** rheumatoid arthritis (MESH:D001172), anemia (MESH:D000740), diabetic foot ulcers (MESH:D017719), neutrophil hyperactivity (MESH:C564275), diabetic complications (MESH:D048909), Death (MESH:D003643), malnourished (MESH:D044342), immunodeficiency diseases (MESH:D007153), end-stage liver/kidney failure (MESH:D007676), infection (MESH:D007239), coagulation dysfunction (MESH:D001778), acute myocardial infarction (MESH:D009203), lower extremity skin ulcers (MESH:D012883), peripheral artery disease (MESH:D058729), type 2 diabetes (MESH:D003924), sepsis (MESH:D018805), tissue injury (MESH:D017695), neuropathy (MESH:D009422), hyperglycemia (MESH:D006943), Inflammatory (MESH:D007249), diseases (MESH:D004194), wounds (MESH:D014947), malignant tumors (MESH:D009369), Diabetic wounds (MESH:D003920), autoimmune diseases (MESH:D001327), type 1, gestational, or secondary diabetes (MESH:D016640), AIDS (MESH:D000163), pneumonia (MESH:D011014), hypoalbuminemia (MESH:D034141)
- **Chemicals:** Mg2+ (-), Na+ (MESH:D012964), K+ (MESH:D011188), Cl- (MESH:D002713), LPS (MESH:D008070), ROS (MESH:D017382), magnesium (MESH:D008274), Glu (MESH:D005947), bilirubin (MESH:D001663), TG (MESH:D014280), advanced glycation end product (MESH:D017127), chloride (MESH:D002712)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935653/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12935653/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935653/full.md

---
Source: https://tomesphere.com/paper/PMC12935653